Discounted Cash Flow Rating

Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Neogen Corp (NEOG)

In Vitro & In Vivo Diagnostic Substances

https://www.neogen.com

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

620 LESHER PLACE
LANSING, MI

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/23/1989

Market Cap

3,518,027,090

Shares Outstanding

216,520,000

Weighted SO

216,520,296

Total Employees

N/A

Upcoming Earnings

07/30/2024

Similar Tickers

QGEN --.--%

OLK --.--%

ACRS --.--%

SYNH --.--%

IQV --.--%

MEDP --.--%

ICLR --.--%

SHC --.--%

RDNT --.--%

Beta

1.1980

Last Div

0.0000

Range

11.46-23.64

Chg

-0.5550

Avg Vol

2025098

Mkt Cap

3518027090

Exch

NASDAQ

Country

US

Phone

517 372 9200

DCF Diff

8.6019

DCF

7.7081

Div Yield

0.0000

P/S

3.8065

EV Multiple

23.2058

P/FV

1.1185

Div Yield %

0.0000

P/E

-373.2803

PEG

-16.0644

Payout

0.0000

Current Ratio

3.8182

Quick Ratio

2.5917

Cash Ratio

1.1055

DSO

68.3243

DIO

150.0742

Op Cycle

218.3985

DPO

65.8610

CCC

152.5375

Gross Margin

0.5019

Op Margin

0.0684

Pretax Margin

-0.0155

Net Margin

-0.0102

Eff Tax Rate

0.3414

ROA

-0.0021

ROE

-0.0030

ROCE

0.0143

NI/EBT

0.6586

EBT/EBIT

-0.2264

EBIT/Rev

0.0684

Debt Ratio

0.1954

D/E

0.2850

LT Debt/Cap

0.2203

Total Debt/Cap

0.2218

Int Coverage

1.7048

CF/Debt

0.0393

Equity Multi

1.4580

Rec Turnover

5.3422

Pay Turnover

5.5420

Inv Turnover

2.4321

FA Turnover

3.1663

Asset Turnover

0.2016

OCF/Share

0.1624

FCF/Share

-0.3520

Cash/Share

0.7891

OCF/Sales

0.0381

FCF/OCF

-2.1681

CF Coverage

0.0393

ST Coverage

4.6595

CapEx Coverage

0.3156

Div&CapEx Cov

0.3156

P/BV

1.1185

P/B

1.1185

P/S

3.8065

P/E

-373.2803

P/FCF

-46.1375

P/OCF

99.9907

P/CF

99.9907

PEG

-16.0644

P/S

3.8065

EV Multiple

23.2058

P/FV

1.1185

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Dec 18, 20:30 Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research Dec 18, 20:30 Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research Dec 18, 20:30 Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research Dec 18, 20:30 Quipt Home Medical Corp. (QIPT) Reports Q4 Loss, Misses Revenue Estimates

Revenue Product Segmentation